STOCK TITAN
  1. Home
  2. News
  3. RMSL

REMSLEEP HOLDINGS INC - $RMSL STOCK NEWS

Welcome to our dedicated page for REMSLEEP HOLDINGS news (Ticker: $RMSL), a resource for investors and traders seeking the latest updates and insights on REMSLEEP HOLDINGS stock.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect REMSLEEP HOLDINGS's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of REMSLEEP HOLDINGS's position in the market.

News
REMSleep Holdings Patent Status
Rhea-AI Summary
REMSleep Holdings, Inc. (RMSL) receives a new patent for Sleep Apnea Cannula and Nasal Pillows Device, with a 15-year expiration. The Firm advises marking products with the patent number U.S. Pat. No. D1017025.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.56%
Tags
none
-
News
REMSleep Holdings Shareholder Update
Rhea-AI Summary
REMSleep Holdings, Inc. (RMSL) provides an update on FDA process and REMSleep status. The company is undergoing shelf-life testing and awaiting results to resubmit its 510(K) application. REMSleep aims to improve CPAP machine comfort and compliance for individuals with severe obstructive sleep apnea (OSA) or OSA complicated by congestive heart failure (CHF).
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
5.71%
Tags
none
-
News
Remsleep Holdings Inc.'s DeltaWave Mask has received questions from FDA regarding 510k submission (K233415)
Rhea-AI Summary
RemSleep Holdings Inc. (RMSL) has received a response regarding the 510(K) submission for their medical device dedicated to treating Obstructive Sleep Apnea (OSA). The FDA has requested additional information and testing related to Administrative Information, Device Description, Substantial Equivalence, Labeling, Biocompatibility, and Performance testing. The company is in the process of providing the required answers and tests. The CEO has assured investors of their commitment to gaining approval for the submission as soon as possible. The company has also applied for a government grant for clinical trials and has been granted a new US patent for their product(s).
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-40%
Tags
none
News
Remsleep Holdings Inc.'s DeltaWave Mask Moves to Substantive Review of FDA 510k Process
Rhea-AI Summary
RemSleep Holdings Inc. announces that its DeltaWave mask has moved to the Substantive Review portion of the FDA 510k review process. The company voluntarily withdrew its 510k submission during the Acceptance Review portion but made changes to address reviewer comments. The current FDA reviewer is the same individual who was assigned to the previous submission. The company is confident in the comprehensive testing regimen and expects the DeltaWave to be safe. Discussions with interested distributors have resumed. RemSleep will provide updates on its website and Twitter feed.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
5.04%
Tags
none
-
News
RemSleep Holdings Inc. Announces Submission of DeltaWave Mask for FDA 510K Review
Rhea-AI Summary
RemSleep Holdings Inc. submits DeltaWave mask for FDA 510K review.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.76%
Tags
none
-
News
RemSleep Holdings Inc. Provides an Update on Funding and DeltaWave
Rhea-AI Summary
RemSleep Holdings Inc. announces new investor agreement and DeltaWave submission update.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-4.15%
Tags
none
News
RemSleep Holdings Inc. Announces Completion of DeltaWave CPAP Mask
Rhea-AI Summary
RemSleep completes testing protocol for 510K clearance of its DeltaWave CPAP Mask, reducing estimate to 2-4 weeks before FDA submission.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
-
News
RemSleep Holdings Inc. Issues Letter to Shareholders
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
6.87%
Tags
none
-
News
RemSleep Holdings Provides a Corporate Update on Testing
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-17.93%
Tags
none
News
RemSleep Holdings Inc. Commences Trading on OTCQB
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
10%
Tags
none
Stock RMSL logo
REMSLEEP HOLDINGS INC

OTC:RMSL

RMSL Rankings

N/A Ranked by Market Cap
N/A Ranked by Stock Gains
N/A Ranked by Dividends

RMSL Stock Data

15.41M
1.41B
3.64%
0.05%
Surgical and Medical Instrument Manufacturing
Manufacturing
Link
United States of America
Tampa

About RMSL

remsleep holdings, inc. focuses on the development and distribution of products to help people affected by sleep apnea worldwide. it offers deltawave cpap interface device to treat patients with sleep apnea. the company serves home care dealers, private sleep labs, internet providers, product end users, physicians, medical group, and hospitals, as well as medical associations. remsleep holdings, inc. was founded in 2007 and is headquartered in orlando, florida.